Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
Author:
Publisher
Frontiers Media SA
Subject
Immunology,Immunology and Allergy
Reference47 articles.
1. Allogeneic stem cell transplantation: a historical and scientific overview.;Singh;Cancer Res.,2016
2. Prophylaxis regimens for GvHD: systemic review and meta-analysis.;Ram;Bone Marr Transplant.,2009
3. Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation.;Przepiorka;Biol Blood Marrow Transplant.,1999
4. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical BMT.;Luznik;Semin Oncol.,2012
5. High-dose cyclophosphamide as single-agent, short course prophylaxis of graft-versus-host disease.;Luznik;Blood.,2010
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation;European Journal of Haematology;2024-08-18
2. CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis;Transplantation and Cellular Therapy;2024-08
3. PTCy-ATG mutually exclusive or additive? Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia;Leukemia & Lymphoma;2024-07-31
4. The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide;Leukemia & Lymphoma;2024-05-06
5. Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients;Bone Marrow Transplantation;2024-04-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3